Preimplantation Genetic  Diagnosis

        

Preimplantation Genetic Diagnosis (PGD) is a state-of-the-art procedure in which an embryo resulting from in vitro fertilization (IVF) is screened for genetic abnormalities before it is transferred into the womb.  During PGD, a single cell is removed (biopsied) from a three-day old embryo and then genetically analyzed.  PGD has been shown to reduce the possibility of a genetically abnormal pregnancy and decrease the incidence of spontaneous miscarriages.

WHO CAN BENEFIT:

• Patients over 35 years old

• Patients with increased risks for age-related chromosomal abnormality in their unborn child

• Patients with a prior history of repeated miscarriages

• Carriers of genetic diseases (recessive genetic or x-linked disorders)

• Patients with known chromosomal abnormalities such as translocations or inversions

 

EXPERIENCE

Family Fertility Center is affiliated with Reprogenetics in New Jersey.  The PGD team is lead by Santiago Munne, Ph.D. and has performed more than 600 cycles and published more than 100 peer-reviewed scientific publications. 

 

CONVENIENCE

The IVF and embryo biopsy are performed at the Family Fertility Center, and the single cell is immediately fixed then sent to Reprogenetics, where it is analyzed.  Reprogenetics provides next-day results to Dr. Lee, who in turn selects the embryos for transfer.